Investigates urinary proteome changes in rats with lithium-induced nephrogenic diabetes insipidus, suggesting potential biomarkers of kidney remodeling.
Lithium (Li) salts have been widely used to treat bipolar disorder and unipolar depression for more than 50 years. However, up to 40% of people taking Li develop Nephrogenic Diabetes Insipidus (NDI). NDI is associated with cellular remodeling in the rodent kidney collecting duct and reduced aquaporin-2. Patients taking Li for more than 10-20 years are at risk of chronic kidney disease, which ultimately can lead to end-stage renal disease, hemodialysis, transplantation, or death. The purpose of this study was to investigate whether the rat urinary proteome can be used as an indicator of Li-induced changes in kidney. Extracellular vesicles were isolated from the urine of rats treated with Li for 2 or 4 weeks followed by LC-MS/MS analysis. The results showed a limited correlation between protein changes in urine and kidney. However, the urine contained markers of mitochondrial dysfunction. The cytoskeletal protein, Keratin 8, showed a tendency to be higher in the urine and was greatly increased in collecting duct principal cells in response to Li, suggesting a potential role in cellular remodeling. Canonical Histone H4 was increased in the urine, and was observed in the nuclei of collecting duct principal and intercalated cells following Li. Moreover, Histone H4 positive cells co-localized with the proliferation marker, PCNA. This correlates with the known increased proliferation in the collecting duct in response to Li. Thus, replication-dependent Histone H4 is a possible urinary marker for the Li induced cellular remodeling of the collecting duct.
No takes yet. Share an insight, caveat, or question.
Grønkjær et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: